News
Built for innovation
AXA IM Alts to invest €1.9 billion in Life Sciences through Kadans Science Partner
AXA IM Alts has raised €1.9 billion of equity to accelerate investments into the Life Sciences sector. The capital raised will primarily be invested through Kadans Science Partner, which will enable Kadans to execute
‘We want to offer much more than just real estate’
‘We want to offer much more than just real estate’ Kadans Science Partner believes in the importance of giving tenants access to an innovation ecosystem that enables parties to strengthen each other. By Anourd